Prokaryotic Expression Systems Market

Prokaryotic Expression Systems Market - An Overview

The global prokaryotic expression systems market is expected to witness strong growth during the forecast period between 2021 and 2031.

Prokaryotic expression systems have been widely deployed for recombinant protein manufacturing in different laboratories and industries, worldwide.

These systems have proven beneficial in procuring large number of recombinant proteins by deploying various bacterial hosts in a short time. As a result, these systems have developed into a key part of proteomic research, leading to growth in the overall prokaryotic expression systems market.

Some of the products commonly used include amino acids, ascorbic acids, enzymes, pigments, and biopolymers.

Prokaryotic Expression Systems Market - Trends and Opportunities

Rising simplicity in genetic modifications globally is the key growth driver for the prokaryotic expression systems market.

Growing demand for therapeutic proteins for human treatment is also anticipated to bolster the overall prokaryotic expression systems market, in future.

Also, increasing availability of different types of amutant bacterial hosts worldwide is projected to contribute to the growth of the overall prokaryotic expression systems market, in future.

In addition to this, growing research activities to develop improved products are expected to fuel the growth in the prokaryotic expression systems market, in the years ahead.

Advancements in molecular biology could positively impact the growth in the overall prokaryotic expression systems market, in the coming years.

E.coli host type is expected to make the largest contribution to the global prokaryotic expression systems market because they have been extensively deployed in the manufacturing of recombinant proteins. The production process using E.coli has proven to be simple and cost-effective, thereby leading to high demand.

Prokaryotic Expression Systems Market - Competitive Landscape

The global prokaryotic expression systems market is extremely competitive, with the presence of several well-established players, many of whom have become successful due to years of delivering consistent results.

Many of these players are expected to account for a large share in the overall prokaryotic expression systems market, in the upcoming years.

Prominent prokaryotic expression systems market players will engage in different growth strategies such as novel product launches, in a bid to gain a competitive edge over the other players.

German market player Qiagen introduced a new product a couple of years ago, comprises of 5 sets of vectors deployed for expression of N-terminally His-tagged proteins. The five vectors, namely, were pQE-9, pQE-30, pQE-31, pQE-32, and pQE-40.

Research and development undertakings to produce improved quality of products could be a key growth strategy for well-established prokaryotic expression systems market players, in future.

Collaboration with smaller players could help leading prokaryotic expression systems market players to expand their market presence and increase their revenue shares.

Some of the leading players in the global prokaryotic expression systems market include Life Technologies Corporation, Takara Bio Inc., Promega Corporation, Agilent Technologies, and Qiagen.

Prokaryotic Expression Systems Market - Regional Assessment

The global prokaryotic expression systems market is classified into five regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

North America is expected to be the dominant region in the global prokaryotic expression systems market in future owing to factors such as continuous advancements to genome sequencing and innovations to proteomics in countries such as US and Canada.

Middle East and Africa is expected to offer profitable growth opportunities for the global prokaryotic expression systems market in future owing to increased investments in research and development undertakings in the region.

Asia Pacific is expected to witness moderate growth in the prokaryotic expression systems market in the years ahead.

Other regions of the world such as Europe and Latin America are expected to witness sluggish growth in the overall market, owing to lack of presence of well-established market players, in countries belonging to both regions.